Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-29 Sale |
2022-08-31 5:45 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $66.84 | $1,671,084 | 348,612 (Direct) |
View |
| 2022-07-27 Sale |
2022-07-29 5:38 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $75.91 | $1,897,747 | 373,612 (Direct) |
View |
| 2022-06-29 Sale |
2022-07-01 6:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $61.59 | $1,539,862 | 298,612 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 8:00 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $128.78 | $3,863,469 | 282,885 (Direct) |
View |
| 2021-06-15 Sale |
2021-06-17 5:44 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $126.43 | $3,792,804 | 251,052 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 6:11 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $213.67 | $4,273,311 | 291,972 (Direct) |
View |
| 2020-12-10 Sale |
2020-12-11 4:05 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $142.29 | $2,845,782 | 311,972 (Direct) |
View |
| 2020-06-01 Sale |
2020-06-03 5:32 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $64.68 | $1,117,266 | 333,530 (Direct) |
View |
| 2020-05-19 Sale |
2020-05-21 4:35 pm |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $65.25 | $978,683 | 542,335 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $16.21 | 348,612 (Direct) |
View |
| 2022-08-29 Exercise |
2022-08-31 5:45 pm |
N/A 2027-05-03 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 348,612 (Direct) |
View |
| 2022-08-16 Option Award |
2022-08-18 5:37 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
16,667 | $16.21 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 373,612 (Direct) |
View |
| 2022-07-27 Exercise |
2022-07-29 5:38 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
8,333 | $12.57 | 373,612 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 7:00 pm |
N/A 2032-06-30 |
Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director |
48,000 | $0 | 48,000 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $0 | 298,612 (Direct) |
View |
| 2022-06-29 Exercise |
2022-07-01 6:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
25,000 | $12.57 | 298,612 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:02 pm |
N/A 2032-06-09 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 7:24 pm |
N/A 2032-05-13 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
49,000 | $0 | 49,000 (Direct) |
View |
| 2022-03-11 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,487 | $62.56 | 329,112 (Direct) |
View |
| 2022-03-10 Exercise |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,834 | $0 | 329,112 (Direct) |
View |
| 2022-03-14 Tax Withholding |
2022-03-14 6:12 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
4,153 | $61.08 | 329,112 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:43 pm |
N/A 2032-02-18 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
168,000 | $0 | 168,000 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $0 | 337,318 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,750 | $1.81 | 337,318 (Direct) |
View |
| 2021-12-06 Tax Withholding |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
37,818 | $69.17 | 301,335 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-07 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
80,000 | $0 | 301,335 (Direct) |
View |
| 2021-12-01 Tax Withholding |
2021-12-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $75.1 | 219,153 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $0 | 338,915 (Direct) |
View |
| 2021-10-15 Option Award |
2021-10-18 8:00 pm |
N/A 2031-10-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
43,000 | $0 | 338,915 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
33,000 | $1.81 | 338,915 (Direct) |
View |
| 2021-09-01 Tax Withholding |
2021-09-03 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
787 | $124.83 | 186,932 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 282,885 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 282,885 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 6:14 pm |
N/A 2031-06-17 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A 2026-07-15 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $0 | 251,052 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-17 5:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
30,000 | $12.57 | 251,052 (Direct) |
View |
| 2021-06-01 Tax Withholding |
2021-06-03 5:34 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $115.8 | 187,719 (Direct) |
View |
Ownership |
2021-05-27 8:31 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | Kulkarni Samarth Director |
0 | $0 | 208,474 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-14 4:55 pm |
N/A 2031-05-13 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
21,000 | $0 | 21,000 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-23 9:14 pm |
N/A 2031-04-19 |
Black Diamond Therapeutics Inc. | BDTX | Kulkarni Samarth Director |
14,921 | $0 | 14,921 (Direct) |
View |
| 2021-03-10 Tax Withholding |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
5,526 | $124.15 | 324,498 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 5:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
11,833 | $0 | 324,498 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-12 5:49 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
136,000 | $0 | 324,498 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 4:13 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
798 | $130.25 | 182,191 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 6:11 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 291,972 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 6:11 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $1.81 | 291,972 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-30 4:02 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,800 | $0 | 311,972 (Direct) |
View |
| 2020-12-29 Exercise |
2020-12-30 4:02 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
13,800 | $1.81 | 311,972 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 4:05 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $0 | 311,972 (Direct) |
View |
| 2020-12-10 Exercise |
2020-12-11 4:05 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
20,000 | $1.81 | 311,972 (Direct) |
View |
| 2020-12-01 Tax Withholding |
2020-12-03 4:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $129.58 | 169,189 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-06 5:45 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
47,333 | $0 | 47,333 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 4:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $94.15 | 169,968 (Direct) |
View |
Ownership |
2020-06-18 9:31 pm |
N/A 2029-11-21 |
Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director |
0 | $0 | 70,933 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 5:32 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $0 | 333,530 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 5:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
17,275 | $1.81 | 333,530 (Direct) |
View |
| 2020-06-02 Tax Withholding |
2020-06-03 5:32 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $66.26 | 333,530 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 4:35 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $0 | 542,335 (Direct) |
View |
| 2020-05-19 Exercise |
2020-05-21 4:35 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
15,000 | $1.81 | 542,335 (Direct) |
View |